  Background. Pneumococcal vaccination (PCV13) for children (as well as older
adults) in Russia was introduced in 2014, with no prior PCV7 use. While
pneumonia hospitalization rates, both in children and adults did not decrease
in the following years, respiratory mortality rates did decline with time.
Moreover, there is a strong association between antibiotic, including multidrug
resistance and PCV13 vaccine serotypes for S. pneumoniae in children in Russia,
and presence of S. pneumoniae among sepsis cases in Russia during the recent
years has been very low. Annual variability in influenza circulation may affect
some of the changes in respiratory mortality rates. Methods. We applied the
inference method from our recent study of influenza-associated mortality in
Russia to relate monthly respiratory mortality rates between 09/2010 and
08/2019 to monthly indices of influenza circulation and baseline rates of
mortality not associated with influenza, allowing for a potential trend in the
baseline rates starting 2015. Results. Baseline rates of respiratory mortality
not associated with influenza decreased with time starting from the 2014/15
season (with each season running from September to August), with the 2018/19
baseline rates of respiratory mortality per 100,000 individuals being lower by
12.41 (95% CI (10.6,14.2)) compared to the 2010-2014 period. Conclusions. While
improvement in care might have contributed to the reduction in the rates of
respiratory mortality not associated with influenza in Russia, the above
temporally consistent reduction is compatible with the gradual replacement of
vaccine serotypes in the transmission and carriage of S. pneumoniae following
the introduction of PCV13. Further work is needed to better understand the
impact of PCV13 on the epidemiology of respiratory infections and related
mortality in Russia.
